Brief: Muneer Satter Reports 4.9% Stake In Aileron Therapeutics As Of April 2, 2024 - SEC Filing
April 16 (Reuters) - Aileron Therapeutics Inc ALRN.O :
* MUNEER A. SATTER REPORTS 4.9% STAKE IN AILERON
THERAPEUTICS INC
AS OF APRIL 2, 2024 - SEC FILING
* MUNEER A. SATTER - HAD PREVIOUSLY REPORTED 5.9% STAKE IN
AILERON
THERAPEUTICS AS OF MARCH 5, 2024
Source text for Eikon: [ID:https://bitly.ws/3i9ya]
Further company coverage: ALRN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rein Therapeutics
See all newsBrief: Rein Therapeutics Receives U.S. FDA Fast Track Designation For Lti-03 In Idiopathic Pulmonary Fibrosis
Rein Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Rein Therapeutics Q2 net loss narrows on lower R&D spending
Rein Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Rein Therapeutics Announces Closing Of $57.5 Million Underwritten Public Offering